Atamyo Therapeutics
Entity

  • Atamyo Therapeutics

    Created in 2020


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,701

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    91000 Évry-Courcouronnes, France

    Évry-Courcouronnes

    France

  • Employees

    Scale: 2-10

    Estimated: 4

  • Engaged catalyst

    1
    0 0

  • Added in Motherbase

    3 months, 2 weeks ago
Description
  • Value proposition

    Changing lives of neuromuscular patients with gene therapy.

    Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases. A spin-off of gene therapy pioneer Genethon, Atamyo leverages unique expertise in AAV-based gene therapy and muscular dystrophies from the Progressive Muscular Dystrophies Laboratory at Genethon. Atamyo’s most advanced programs address different forms of limb-girdle muscular dystrophies (LGMD). The name of the company is derived from two words: Celtic Atao which means “Always” or “Forever” and Myo which is the Greek root for muscle. Atamyo conveys the spirit of its commitment to improve the life of patients affected by neuromuscular diseases with life-long efficient treatments.

    Gene Therapy, Neuromuscular diseases, Muscle distrophy, LGMD-R9/2I, LGMD, LGMD-R5/2C, LGMD-R1/2A, LGMD-R3/2D, and LGMD6R2/2B

  • Original language

    Changing lives of neuromuscular patients with gene therapy.

    Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases. A spin-off of gene therapy pioneer Genethon, Atamyo leverages unique expertise in AAV-based gene therapy and muscular dystrophies from the Progressive Muscular Dystrophies Laboratory at Genethon. Atamyo’s most advanced programs address different forms of limb-girdle muscular dystrophies (LGMD). The name of the company is derived from two words: Celtic Atao which means “Always” or “Forever” and Myo which is the Greek root for muscle. Atamyo conveys the spirit of its commitment to improve the life of patients affected by neuromuscular diseases with life-long efficient treatments.

  • Atamyo | Gene Therapy for LGMD Patients

    Atamyo brings to patients with musculoskeletal diseases a new generation of best-in-class gene therapies with enhanced safety and efficacy.

    • https://atamyo.com/
Catalyst interactions
Catalyst TypeTweets Articles
France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research 		Other

28 Feb 2025


Social network dynamics
Last news
Show all articles